We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




LIMS to Be Deployed to FDA Testing Laboratories

By LabMedica International staff writers
Posted on 01 Feb 2012
A software-based laboratory information management system (LIMS) will be used to manage complicated processes and the analysis of the massive amounts of data generated by the US Food and Drug Administration (FDA) laboratories.

Abbott (Abbott Park, IL, USA) announced that the FDA would begin implementing Abbott’s STARLIMS software-based LIMS as part of the agency’s initiative to enhance FDA testing laboratories. More...


As part of a master agreement with Dovèl Technologies (McLean, VA, USA), a company that provides high-end software applications to government organizations, the FDA’s Office of Regulatory Affairs (ORA; Silver Spring, MD, USA) will begin deploying LIMS solutions from STARLIMS, developed to enhance testing of food and drug chemistries, devices, forensics material, and microbiology samples. The ORA operates chiefly five types of laboratories in 14 separate locations. The LIMS solution will provide the needed capability to manage the analytic workflow operations in ORA labs for about 825 users supporting sample accountability, data analysis, document control, report generation, and other lab operation functions.

“We’re looking forward to working on this important initiative,” said Isaac Friedman, head of Abbott’s STARLIMS business. “STARLIMS has a successful track record in implementing web-based LIMS for life sciences organizations, public health laboratories, and a number of federal agencies.”

Based in Hollywood (FL, USA), Abbott’s STARLIMS business is a provider of laboratory information management systems, with more than 20 years of LIMS experience. STARLIMS products help improve the effectiveness of laboratory-sampling processes, support compliance with domestic and international regulations and industry standards, and provide comprehensive reporting, monitoring, and analysis capabilities. STARLIMS software is used for quality assurance and control, testing, and monitoring, and research and development in government, manufacturing, and life sciences organizations.

Abbott is a global healthcare company focused on the discovery, development, manufacture, and marketing of pharmaceuticals and medical products, including nutrition products, devices, and diagnostics.

Related Links:
STARLIMS
Dovèl Technologies
US Food and Drug Administration’s Office of Regulatory Affairs


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.